COFECE: more generic drug competition needed
Credit: iStock.com/viperfzk
Mexico's antitrust watchdog says the country needs to remove regulatory barriers to generic drug competition.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now